Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Hemostatic Powder (Endo-clotTM) in Success and Prevention of Bleeding Within Gastric Cancer Patients With Bleeding

NCT02732483 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT02732483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02732483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Hemostatic Powder (Endo-clotTM) in Success and Prevention of Bleeding Within Gastric Cancer Patients With Bleeding
Lead sponsor
Yonsei University
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2016
Completion date
April 30, 2018
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding at gastric cancer